Thalys Medical Technology Group Inc. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was CNY 2,589.56 million compared to CNY 2,123.98 million a year ago. Revenue was CNY 2,599.55 million compared to CNY 2,125.47 million a year ago. Net loss was CNY 49.51 million compared to net income of CNY 57.56 million a year ago. Basic loss per share from continuing operations was CNY 0.2524 compared to basic earnings per share from continuing operations of CNY 0.29 a year ago. Diluted loss per share from continuing operations was CNY 0.2524 compared to diluted earnings per share from continuing operations of CNY 0.29 a year ago.